Healthcare Realty Trust Inc. Files 10-Q for Period Ending March 31, 2024

TL;DR

<b>Healthcare Realty Trust Inc. filed its Q1 2024 10-Q, detailing financial data and historical company information.</b>

AI Summary

Healthcare Realty Trust Inc (HR) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. Filing is a 10-Q for Healthcare Realty Trust Inc. for the period ending March 31, 2024. The company's former name was Healthcare Trust of America, Inc. The filing includes data related to common stock, additional paid-in capital, and accumulated other comprehensive income. Data points cover periods including Q1 2024, Q1 2023, and year-end 2023. The filing references US GAAP standards for financial reporting.

Why It Matters

For investors and stakeholders tracking Healthcare Realty Trust Inc, this filing contains several important signals. This 10-Q provides investors with the latest quarterly financial performance and position of Healthcare Realty Trust Inc. Understanding the details in this filing is crucial for assessing the company's financial health and investment potential.

Risk Assessment

Risk Level: low — Healthcare Realty Trust Inc shows low risk based on this filing. The filing is a standard quarterly report (10-Q) with no immediate red flags or significant negative disclosures apparent from the provided metadata.

Analyst Insight

Review the detailed financial statements and management discussion within the full 10-Q to understand operational performance and future outlook.

Key Numbers

• 2024-03-31 — Period of Report (Quarterly filing date)
• 2024-05-07 — Filed As Of Date (Date of submission)
• 2024-01-01 — Quarter Start Date (Q1 2024 reporting period)
• 2023-12-31 — Previous Year End (Reference date for comparative data)

Key Players & Entities

• Healthcare Realty Trust Inc. (company) — Filer name
• Healthcare Trust of America, Inc. (company) — Former company name
• 2024-03-31 (date) — Period of report
• 2024-05-07 (date) — Filed as of date

FAQ

Industry Context

Healthcare Realty Trust Inc. operates as a Real Estate Investment Trust (REIT) primarily focused on healthcare properties.

Regulatory Implications

The filing adheres to the requirements of the Securities Exchange Act of 1934, specifically Form 10-Q for quarterly reporting.

What Investors Should Do

1. Analyze the balance sheet for changes in assets, liabilities, and equity compared to the prior period.
2. Examine the statement of operations for revenue trends and profitability metrics.
3. Review any disclosures related to debt, interest rates, or significant contractual obligations.

Year-Over-Year Comparison

This is the initial 10-Q filing for the period ending March 31, 2024, providing the most current financial data.

Key Financial Figures

• $0.01 — Which Registered Class A Common Stock, $0.01 par value per share HR New York Stock E

Filing Documents

• hr-20240331.htm (10-Q) — 1039KB
• hr-2024331xex22.htm (EX-22) — 6KB
• hr-2024331xex311.htm (EX-31.1) — 11KB
• hr-2024331xex312.htm (EX-31.2) — 11KB
• hr-2024331xex32.htm (EX-32) — 7KB
• 0001360604-24-000045.txt (&nbsp;) — 7068KB
• hr-20240331.xsd (EX-101.SCH) — 58KB
• hr-20240331_cal.xml (EX-101.CAL) — 99KB
• hr-20240331_def.xml (EX-101.DEF) — 266KB
• hr-20240331_lab.xml (EX-101.LAB) — 728KB
• hr-20240331_pre.xml (EX-101.PRE) — 496KB
• hr-20240331_htm.xml (XML) — 931KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION Item 1

Financial Statements

Financial Statements 1 Condensed Consolidated Balance Sheets 1 Condensed Consolidated Statements of Operations 2 Condensed Consolidated Statements of Comprehensive Loss 3 Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests 4 Condensed Consolidated Statements of Cash Flows 5 Notes to the Condensed Consolidated Financial Statements 6 Item 2

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 20 Item 3

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 29 Item 4

Controls and Procedures

Controls and Procedures 29

- OTHER INFORMATION

PART II - OTHER INFORMATION Item 1

Legal Proceedings

Legal Proceedings 29 Item 1A

Risk Factors

Risk Factors 29 Item 2 Unregistered Sales of Equity and Use of Proceeds 30

Other Information 30

Item 5 Other Information 30 Item 6 Exhibits 30 SIGNATURE 32 Table of Contents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements Healthcare Realty Trust Incorporated Condensed Consolidated Balance Sheets Amounts in thousands, except per share data ASSETS Unaudited MARCH 31, 2024 DECEMBER 31, 2023 Real estate properties Land $ 1,342,895 $ 1,343,265 Buildings and improvements 10,902,835 10,881,373 Lease intangibles 816,303 836,302 Personal property 12,720 12,718 Investment in financing receivable, net 122,001 122,602 Financing lease right-of-use assets 81,805 82,209 Construction in progress 70,651 60,727 Land held for development 59,871 59,871 Total real estate properties 13,409,081 13,399,067 Less accumulated depreciation and amortization ( 2,374,047 ) ( 2,226,853 ) Total real estate properties, net 11,035,034 11,172,214 Cash and cash equivalents 26,172 25,699 Assets held for sale, net 30,968 8,834 Operating lease right-of-use assets 273,949 275,975 Investments in unconsolidated joint ventures 309,754 311,511 Goodwill — 250,530 Other assets, net 605,047 592,368 Total assets $ 12,280,924 $ 12,637,131 LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities Notes and bonds payable $ 5,108,279 $ 4,994,859 Accounts payable and accrued liabilities 163,172 211,994 Liabilities of assets held for sale 700 295 Operating lease liabilities 229,223 229,714 Financing lease liabilities 74,769 74,503 Other liabilities 197,763 202,984 Total liabilities 5,773,906 5,714,349 Commitments and contingencies Redeemable non-controlling interests 3,880 3,868 Stockholders' equity Preferred stock, $ .01 par value per share; 200,000 shares authorized; none issued and outstanding — — Class A Common stock, $ .01 par value per share; 1,000,000 shares authorized; 381,502 and 380,964 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively 3,815 3,810 Additional paid-in capital 9,609,530 9,602,592 Accumulated other comprehensive income (loss) 4,791 ( 10,741 ) Cumulative net income attributable to common stockholders 717,958 1,028,

View Full Filing

View this 10-Q filing on SEC EDGAR